How do we unpack the full meaning of patient diversity in clinical trials? The lack of equity and representation of minority groups in biomedical research has been an open concern for many years despite regulatory and private-sector initiatives. Now, there is reason to hope for significant change, spurred by heightened awareness of racial discrimination in US healthcare and COVID-19's disproportionate toll on disadvantaged communities.
This four-part webinar series will identify obstacles that have to-date, and continue to, stifle appropriate patient diversity in clinical trials; unpack the organizational overhaul needed to effect change; share case studies where sponsors, patients and investigators have come together to overcome hurdles; and explore how policy innovations that might include government-led mandates and incentives can move the industry forward as one.
